Jones Trading Downgrades Theravance Biopharma (TBPH) to Hold
Tweet
Share
E-mailGet Alerts TBPH Hot Sheet
Price: $16.81 -0.18%
Rating Summary:
4 Buy, 10 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Rating Summary:
4 Buy, 10 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Join SI Premium – FREE
Jones Trading analyst Debanjana Chatterjee downgraded Theravance Biopharma (NASDAQ: TBPH) from Buy to Hold.
For an analyst ratings summary and ratings history on Theravance Biopharma click here. For more ratings news on Theravance Biopharma click here.
Shares of Theravance Biopharma closed at $17.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
- Wex, Inc. (WEX) Tops Q2 EPS by 29c; raises guidance
- Oceaneering (OII) Tops Q2 EPS by 19c
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
